World's Best Scientists 2026 revealed!
Therapeutic Advances in Endocrinology and Metabolism
H-index 18

Therapeutic Advances in Endocrinology and Metabolism

2042-0188

Published by: SAGE

https://journals.sagepub.com/home/tae

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1827 51 42 14

Additional Metrics

Number of Best Scientists*: 66
Documents by Best Scientists*: 56
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 49
SCIMAGO SJR: 1.381
Impact Factor: 4.6

Overview

Top Research Topics at Therapeutic Advances in Endocrinology and Metabolism?

The objective of Therapeutic Advances in Endocrinology and Metabolism is to combine knowledge in the areas of Internal medicine, Diabetes mellitus, Endocrinology, Type 2 diabetes and Type 2 Diabetes Mellitus. While Therapeutic Advances in Endocrinology and Metabolism focused on Internal medicine, it was also able to explore topics like Gastroenterology and Cardiology. Diabetes mellitus research featured in the journal incorporates concerns from various other topics such as Disease and Intensive care medicine.

The research on Disease discussed in the journal draws on the closely related field of Bioinformatics. Therapeutic Advances in Endocrinology and Metabolism connects research in Endocrinology with the related topic of Receptor. The Type 2 Diabetes Mellitus works featured in Therapeutic Advances in Endocrinology and Metabolism incorporate elements from Liraglutide and Pharmacology.

Therapeutic Advances in Endocrinology and Metabolism emphasizes research on Pharmacology, which includes concerns such as Adverse effect. The main emphasis of Therapeutic Advances in Endocrinology and Metabolism is the subject of Insulin, focusing on Hypoglycemia. It focused on Insulin resistance research conducted under the discipline of Obesity.

  • Internal medicine (46.61%)
  • Diabetes mellitus (30.62%)
  • Endocrinology (27.37%)

What are the most cited papers published in the journal?

  • GLP-1 receptor agonists: a review of head-to-head clinical studies (192 citations)
  • Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy (113 citations)
  • Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis. (109 citations)

Research areas of the most cited articles at Therapeutic Advances in Endocrinology and Metabolism:

The published articles generally zeroe in on subjects such as Internal medicine, Endocrinology, Diabetes mellitus, Pharmacology and Insulin resistance. The most cited articles explore topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology and Bioinformatics. The most cited articles explore Diabetes mellitus concepts, specifically Glycemic, Type 2 diabetes and Lipid profile but expand to research in In patient.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Diabetes mellitus
  • Disease

The previous edition focused in particular on these issues:

Therapeutic Advances in Endocrinology and Metabolism focuses on Internal medicine, Diabetes mellitus, Type 2 diabetes, Type 2 Diabetes Mellitus and Disease. Some problems in Internal medicine that were presented in Therapeutic Advances in Endocrinology and Metabolism overlapped with concepts under Gastroenterology, Endocrinology and Oncology. The work on Endocrinology tackled in it brings together disciplines like Monoclonal antibody and Recombinant DNA.

Telemedicine, Asymptomatic, Heart failure and Intensive care medicine are some topics wherein Diabetes mellitus research discussed in it have an impact. While Type 2 diabetes is the focus of Therapeutic Advances in Endocrinology and Metabolism, it also provided insights into the studies of Metformin, Kidney disease, Receptor, Head to head and Pharmacology. Therapeutic Advances in Endocrinology and Metabolism focuses on Disease but the discussions also offer insight into other areas such as Global health and Immunology.

The most cited articles from the last journal are:

  • Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis (11 citations)
  • Advancements in the treatment of differentiated thyroid cancer. (4 citations)
  • GLP-1 receptor agonists: an updated review of head-to-head clinical studies: (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Therapeutic Advances in Endocrinology and Metabolism (based on the number of publications) are:

  • Gaurav S Gulsin (6 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Gerry P McCann (6 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Christoph Schindler (6 papers) absent at the last edition,
  • Jennifer M. Trujillo (6 papers) published 1 paper at the last edition,
  • Thozhukat Sathyapalan (6 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutic Advances in Endocrinology and Metabolism (based on the number of publications) are:

  • University of Leicester (8 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • New York University (7 papers) absent at the last edition,
  • Harvard University (7 papers) published 1 paper at the last edition,
  • University of Birmingham (6 papers) absent at the last edition,
  • American University of Beirut (6 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.55% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 26.19% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.76% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.05% of all publications and 50.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

The Evolution of Research in Therapeutic Advances in Endocrinology and Metabolism

The vast fields of internal medicine, endocrinology, and diabetes mellitus have witnessed significant advancements over the years, hence the research topics and sub-disciplines continue to evolve. For instance, in recent years, there's an increased focus on the link between nutrition and endocrinology, intricately exploring how dietary factors can influence hormonal balance in the body. Also, there is remarkable progress in the exploration of gene therapy as a potential solution for chronic diseases such as Diabetes Mellitus type 1 and type 2. One of the future research directions also includes the utilization of artificial intelligence (AI) and machine learning in endocrinology and metabolism. These technologies are being used to develop sophisticated models for disease prediction, diagnostic imaging, and genetic analysis—enhancing understanding, diagnosis, treatment, and management of endocrine diseases. Moreover, the ever-growing demand for personalized medicine is expected to reshape future research in endocrinology and metabolism, with more emphasis on genetic profiling and tailor-made therapeutic strategies. While the growth of the subject is exciting, it is also vital that researchers and healthcare professionals engaged in these fields continue to pursue further knowledge and skills. To meet the advancements in the field, professionals might need to upskill continually. For instance, those based in Ohio may refer to the ohio nursing license requirements or seek advanced training in specialized areas like genetic engineering or artificial intelligence applications in healthcare. Indeed, the continuing evolution of research in therapeutic advances in endocrinology and metabolism presents a brighter future, bringing new perspectives and offering more holistic approaches to patient care.

Top Publications

  • MAFLD: a multisystem disease

    (2023)
    123 Citations
  • Effects of metformin in obesity treatment in different populations: a meta-analysis

    (2020)
    58 Citations
  • Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?

    Regitse Højgaard Christensen;Bernt Johan von Scholten;Louise Lang Lehrskov;Peter Rossing

    (2020)
    47 Citations
  • Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome

    Punith Kempegowda;Eka Melson;Konstantinos N Manolopoulos;Wiebke Arlt

    (2020)
    41 Citations
  • Vitamin D supplementation after the menopause

    Faustino R. Pérez-López;Peter Chedraui;Stefan Pilz

    (2020)
    36 Citations
  • New perspectives on the treatment of skeletal dysplasia.

    Pauline Marzin;Valérie Cormier-Daire

    (2020)
    35 Citations
  • Hypoglycaemia and cardiac arrhythmias in diabetes.

    Andreas Andersen;Peter G Jørgensen;Filip K Knop;Tina Vilsbøll

    (2020)
    30 Citations
  • Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control:

    Jelena P Seferovic;Scott D Solomon;Ellen W Seely

    (2020)
    28 Citations
  • Digital health and diabetes: experience from India.

    Jothydev Kesavadev;Gopika Krishnan;Viswanathan Mohan

    (2021)
    26 Citations
  • Glucocorticoids in Graves' orbitopathy: mechanisms of action and clinical application.

    Jan Längericht;Irene Krämer;George J. Kahaly

    (2020)
    26 Citations

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to various complementary career options in healthcare. For individuals interested in nursing, accelerated bsn programs for non nurses offer a streamlined pathway to earn a Bachelor of Science in Nursing quickly, even without prior nursing experience.

For practicing nurses aiming to advance their careers, exploring the fastest rn to bsn program online can provide an efficient route to upgrade credentials and potentially increase job prospects and salary.

Those looking to specialize further can consider fast track nurse practitioner programs, allowing for a more rapid transition into advanced clinical roles.

Specializing in psychiatric care is another evolving field. Understanding the dnp pmhnp salary by state can guide career decisions for Psychiatric-Mental Health Nurse Practitioners, highlighting the potential financial benefits tied to this specialized degree.

Best Scientists Contributing to This Journal

Recently Published Articles